My Quote Request
No products added yet
6505-01-261-4850
20 Products
NDC00021-4401-23
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION,USP
NSN, MFG P/N
6505012614850
NSN
6505-01-261-4850
NDC00021-4401-23
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION,USP
NSN, MFG P/N
6505012614850
NSN
6505-01-261-4850
MFG
SCHWARZ PHARMA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.980 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 6.720 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 5.840 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 22.720 GRAMS SODIUM SULFATE ACTIVE INGREDIENT AND 240.000 GRAMS POLYETHYLENE GLYCOL 3350 ACTIVE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 278.260 GRAMS
PRIMARY CONTAINER TYPE: JUG
SPECIAL FEATURES: FOR RECONSTITUTION TO 4 LITERS
~1: INGREDIENT
Related Searches:
NDC00548-6560-00
METRONIDAZOLE INJECTION,USP
NSN, MFG P/N
6505012604977
NSN
6505-01-260-4977
NDC00548-6560-00
METRONIDAZOLE INJECTION,USP
NSN, MFG P/N
6505012604977
NSN
6505-01-260-4977
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METRONIDAZOLE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00024-1937-04
PENTAZOCINE HYDROCH
NSN, MFG P/N
6505012606049
NSN
6505-01-260-6049
MFG
STERLING-WINTHROP RESEARCH INSTITUTE A DIV OF STERLING DRUG INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EQUIVALENT TO 25 MG. PENTAZOCINE BASE AND 650 MG. ACETAMINOPHEN; CAPSULE SHAPED; BOTTLE OF 100
Related Searches:
TALACEN CAPLETS
PENTAZOCINE HYDROCH
NSN, MFG P/N
6505012606049
NSN
6505-01-260-6049
MFG
STERLING-WINTHROP RESEARCH INSTITUTE A DIV OF STERLING DRUG INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EQUIVALENT TO 25 MG. PENTAZOCINE BASE AND 650 MG. ACETAMINOPHEN; CAPSULE SHAPED; BOTTLE OF 100
Related Searches:
0081-0631-20
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012606058
NSN
6505-01-260-6058
0081-0631-20
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012606058
NSN
6505-01-260-6058
MFG
BURROUGHS WELLCOME CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS LEUCOVORIN EQUIVALENT
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
910
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012606058
NSN
6505-01-260-6058
MFG
BURROUGHS WELLCOME CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS LEUCOVORIN EQUIVALENT
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00081-0631-20
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012606058
NSN
6505-01-260-6058
NDC00081-0631-20
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012606058
NSN
6505-01-260-6058
MFG
BURROUGHS WELLCOME CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS LEUCOVORIN EQUIVALENT
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
WELLCOVORIN TABLETS
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012606058
NSN
6505-01-260-6058
WELLCOVORIN TABLETS
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012606058
NSN
6505-01-260-6058
MFG
BURROUGHS WELLCOME CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS LEUCOVORIN EQUIVALENT
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ADD-VANTAGE NS
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012606715
NSN
6505-01-260-6715
ADD-VANTAGE NS
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012606715
NSN
6505-01-260-6715
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 0.9% 250ML BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: SINGLE DOSE; BAGS HAVE OVERPOUCHES; CAPACITY OF NOT LESS THAN 300 ML; C/O ONE OUTLET PORT FORCE-FITTED W/STERILITY PROTECTOR W/TAB; ONE TAMPER RESISTANT INLET PORT W/HERMETICALLY SEALED STERILITY PROTECTOR W/RING; COMPLEMENTARY GLASS SMALL VOLUME
TOTAL PRIMARY CONTAINER QUANTITY: 24
~1: PARENTERAL VIALS; COMPATIBLE W/INTRAVENOUS INJECTION SETS 6515-00-115-0032,6515-00-140-0888,6515-00-185-5158,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703 AND 6515-01-153-5669
Related Searches:
NDC00074-7101-02
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012606715
NSN
6505-01-260-6715
NDC00074-7101-02
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012606715
NSN
6505-01-260-6715
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 0.9% 250ML BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: SINGLE DOSE; BAGS HAVE OVERPOUCHES; CAPACITY OF NOT LESS THAN 300 ML; C/O ONE OUTLET PORT FORCE-FITTED W/STERILITY PROTECTOR W/TAB; ONE TAMPER RESISTANT INLET PORT W/HERMETICALLY SEALED STERILITY PROTECTOR W/RING; COMPLEMENTARY GLASS SMALL VOLUME
TOTAL PRIMARY CONTAINER QUANTITY: 24
~1: PARENTERAL VIALS; COMPATIBLE W/INTRAVENOUS INJECTION SETS 6515-00-115-0032,6515-00-140-0888,6515-00-185-5158,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703 AND 6515-01-153-5669
Related Searches:
77824
CHLORPROTHIXENE TABLETS,USP
NSN, MFG P/N
6505012607876
NSN
6505-01-260-7876
MFG
ROCHE LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CHLORPROTHIXENE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00004-0046-01
CHLORPROTHIXENE TABLETS,USP
NSN, MFG P/N
6505012607876
NSN
6505-01-260-7876
NDC00004-0046-01
CHLORPROTHIXENE TABLETS,USP
NSN, MFG P/N
6505012607876
NSN
6505-01-260-7876
MFG
ROCHE LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CHLORPROTHIXENE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
TARACTAN TABLETS
CHLORPROTHIXENE TABLETS,USP
NSN, MFG P/N
6505012607876
NSN
6505-01-260-7876
TARACTAN TABLETS
CHLORPROTHIXENE TABLETS,USP
NSN, MFG P/N
6505012607876
NSN
6505-01-260-7876
MFG
ROCHE LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CHLORPROTHIXENE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
INDOCIN
INDOMETHACIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505012610514
NSN
6505-01-261-0514
INDOCIN
INDOMETHACIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505012610514
NSN
6505-01-261-0514
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS INDOMETHACIN PER 5 MILLILITERS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INDOMETHACIN ORAL SUSPENSION 237ML BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 237.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MEDSEP ITEM FOR DOD,MERCH-SHARP AND DOHME
Related Searches:
INDOCIN ORAL SUSPENSION
INDOMETHACIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505012610514
NSN
6505-01-261-0514
INDOCIN ORAL SUSPENSION
INDOMETHACIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505012610514
NSN
6505-01-261-0514
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS INDOMETHACIN PER 5 MILLILITERS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INDOMETHACIN ORAL SUSPENSION 237ML BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 237.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MEDSEP ITEM FOR DOD,MERCH-SHARP AND DOHME
Related Searches:
NDC00006-3376-66
INDOMETHACIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505012610514
NSN
6505-01-261-0514
NDC00006-3376-66
INDOMETHACIN ORAL SUSPENSION,USP
NSN, MFG P/N
6505012610514
NSN
6505-01-261-0514
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS INDOMETHACIN PER 5 MILLILITERS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INDOMETHACIN ORAL SUSPENSION 237ML BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 237.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MEDSEP ITEM FOR DOD,MERCH-SHARP AND DOHME
Related Searches:
15370
METHYLTESTOSTERONE TABLETS,USP
NSN, MFG P/N
6505012610544
NSN
6505-01-261-0544
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS METHYLTESTOSTERONE ACTIVE INGREDIENT
ADMINISTRATION: SUBLINGUAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
METANDREN TABLETS
METHYLTESTOSTERONE TABLETS,USP
NSN, MFG P/N
6505012610544
NSN
6505-01-261-0544
METANDREN TABLETS
METHYLTESTOSTERONE TABLETS,USP
NSN, MFG P/N
6505012610544
NSN
6505-01-261-0544
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS METHYLTESTOSTERONE ACTIVE INGREDIENT
ADMINISTRATION: SUBLINGUAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-0185-01
METHYLTESTOSTERONE TABLETS,USP
NSN, MFG P/N
6505012610544
NSN
6505-01-261-0544
NDC00182-0185-01
METHYLTESTOSTERONE TABLETS,USP
NSN, MFG P/N
6505012610544
NSN
6505-01-261-0544
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS METHYLTESTOSTERONE ACTIVE INGREDIENT
ADMINISTRATION: SUBLINGUAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
COLYTE POWDER
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION,USP
NSN, MFG P/N
6505012614850
NSN
6505-01-261-4850
COLYTE POWDER
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION,USP
NSN, MFG P/N
6505012614850
NSN
6505-01-261-4850
MFG
SCHWARZ PHARMA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.980 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 6.720 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 5.840 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 22.720 GRAMS SODIUM SULFATE ACTIVE INGREDIENT AND 240.000 GRAMS POLYETHYLENE GLYCOL 3350 ACTIVE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 278.260 GRAMS
PRIMARY CONTAINER TYPE: JUG
SPECIAL FEATURES: FOR RECONSTITUTION TO 4 LITERS
~1: INGREDIENT
